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Abstract
Signalling pathways are well-known abstractions that explain the mech-
anisms whereby cells respond to signals. Collections of pathways form net-
works, and interactions between pathways in a network, known as cross-talk,
enables further complex signalling behaviours. While there are several formal
modelling approaches for signalling pathways, none make cross-talk explicit;
the aim of this paper is to define and categorise cross-talk in a rigorous
way. We define a modular approach to pathway and network modelling,
based on the modules construct in the PRISM modelling language, and a
set of generic signalling modules. Five different types of cross-talk are de-
fined according to various biologically meaningful combinations of variable
sharing, synchronisation labels and reaction renaming. The approach is il-
lustrated with a case-study analysis of cross-talk between the TGF-β, WNT
and MAPK pathways.
1. Introduction
Signalling pathways1 are well-known abstractions that explain how cells
respond to signals. They comprise biochemical reactions that transfer infor-
mation from a receptor to a target such as the nucleus or mitochondria. Sev-
eral agent-based, formal modelling techniques from computer science have
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1we refer simply to pathways henceforth
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been extended and applied to signalling pathways in recent years, for ex-
ample, rewrite rules [1], Petri nets [2] and process algebras [3, 4, 5, 6, 7].
However, there has been less focus on collections of pathways that form net-
works, and very little on the interactions between pathways, known in the
life sciences as cross-talk. Cross-talk accounts for many useful behaviours,
for example, producing a variety of responses to a single signal, and reuse
of proteins between pathways. Cross-talk is an essential aspect of network
behaviour, yet there are no known formal models of pathways that make
cross-talk explicit. Here we aim to develop a formal framework for pathway
and network modelling that allows one to explain, categorise, and detect
cross-talk in a systematic way. Our long term motivation is to develop pre-
dictive models that inform both systems and synthetic biology.
The paper has four parts. First, we develop a modular modelling frame-
work for pathways and networks, based on the modules construct in the
PRISM modelling language and multiway synchronisation. We define a set
of generic pathway modules, including basic signalling pathway behaviours
such as receptor, 3-stage cascade and gene expression. A pathway is a com-
position of (instances of) the generic modules; a network is a composition of
pathways. We assume continuous-time Markov chain (CTMC) semantics.
Second, we give our main contribution, which is to define and categorise
cross-talk according to the way pathways are composed to form a network.
Specifically, we consider the combinations of variable sharing, synchronisa-
tion labels and reaction renamings that can give rise to biologically mean-
ingful behaviours. We define five types of cross-talk: substrate availability,
signal flow, receptor function, gene expression and intracellular communica-
tion, and show that the categorisation is well-defined. We can also generate
all possible cross-talk from a given network, which provides a rigorous way
of generating hypotheses to explain data. We give illustrative examples of
each type of cross-talk from biological literature. While we cannot prove
our categorisation is complete, we have been unable to find a cross-talk that
cannot be categorised.
Third, we apply the approach to a case-study involving three pathways
concerning cell growth and differentiation: the TGF-β, WNT and MAPK
pathways. One interesting result is that we are able to resolve an ambiguity
in the literature concerning one complicated form cross-talk between the
WNT and TGF-β pathways.
Finally, we discuss briefly how cross-talk can be detected and categorised
for a given model, in the absence of a model description. Such an approach
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may be useful when we have a model that has been derived from data, rather
than the modular description, which may be more appropriate in a synthetic
setting (i.e. the design of networks and cross-talk).
The paper is organised as follows.
The following section outlines the background to pathway cross-talk, the
temporal logics used in analysis, and related work on pathway and cross-talk
modelling.
Sections 3 – 5 contribute to the first part of the paper. Section 3 describes
the reagent-centric approach to modelling in the PRISM language. Each
reagent in a reaction is mapped to a process, which is represented by a
PRISM module with reaction-labelled transitions. Modules are composed
using multiway synchronisation over sets of labels. We define two extensions
to the language, to allow for variable sharing and synchronisation over labels
within a module. In Section 4 we give an example set of generic modules
and then define a pathway as a composition of (instances of) those modules,
modulo label renaming and hiding. In Section 5 we define a network as a
composition of two pathways, possibly with variable sharing, renaming and
synchronisation of labels.
Sections 6 and 7 define and categorise cross-talk. In Section 6 we define
how the generic modules can be extended with additional reactions, and
then define cross-talk in terms of the synchronisations and variable sharings
in a network. Section 7 gives our categorisation of the five types of cross-
talk. Examples of each are drawn from biological literature and illustrated
using two simple pathways; we give a theorem showing that categorisation is
well-defined. We give an algorithm to enumerate all cross-talks between two
pathways and apply it to the example pathways. We discuss (in Section 6)
how to generalise to higher order networks (i.e. three or more pathways), but
explain why for practical purposes we have focused on pairwise composition.
In the next sections we give preliminary results on the complementary
problem – how to detect (Section 8) and characterise (Section 9) cross-talk
in the absence of a model description.
The case-study is in Section 10, where we define a richer set of generic
modules, and then apply our approach to the cross-talk between TGF-β,
WNT and MAPK pathways, and compare our results with those in the lit-
erature.
There follows a discussion in Section 11, and in Section 12 we give our
conclusions and directions for future work.
3
2. Background
In this section we outline the background to pathway cross-talk, temporal
logics, and related work on pathway and cross-talk modelling.
2.1. Signal transduction: networks, pathways and cross-talk
A cell has many types of receptors that detect extra- or intra-cellular
biochemical signals; signal transduction is the mechanism whereby a cell re-
sponds to a detected signal. The result is a signalling network – a collection
of pathways that comprise biochemical reactions that transfer information
from a receptor to a target such as the nucleus or mitochondria. A typi-
cal response initiated at the target is a change in gene expression/protein
activation levels, resulting in phenotype changes.
Pathways were first thought to be a linear series of reactions, but more re-
cent results indicate they are non-linear [8]. Many of the reactions involved in
signalling pathways are enzyme catalysed protein activations, often arranged
in a “signalling cascade”. In such a cascade, the activated protein on one
“level” is the enzyme for the activating reaction of the next “level,” as shown
in Figure 1 using standard biochemical graphical notation. The series of re-
actions forming the pathway can diverge or interact upstream/downstream
in the chain of reactions forming a feedback/feedforward loop. We note that
pathways are a human abstraction, based on laboratory experiments, to ex-
plain and structure the coordination of cellular activity. Although there is a
well-known set of pathways in biological literature, there is a lack of rigorous
definitions of what constitutes a single pathway and cross-talk between path-
ways. This paper focuses on defining cross-talk between signalling pathways.
The term cross-talk was first applied to electronic circuits to describe a
signal in one circuit having an undesired effect on another circuit [9]. Cross-
talk in this setting is a design flaw: the electronic circuit has been specified
and built, and has resulted in an undesired interaction between signals, called
“signal interference.” Biochemical cross-talk [10] is an interaction between
signals flowing through two or more signalling pathways in a cell, however,
this is not necessarily indicative of signal interference.
We summarise the three fundamental concepts: networks, pathways and
cross-talk, as follows.
Pathway: an abstraction that helps life scientists structure the coordi-
nation of cellular activity.
Cross-talk: the interaction of two or more pathways.
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Network: a collection of pathways and cross-talk that govern how the
cell responds to incoming signals.
Throughout the paper the following notation is used. A reaction, for
example protein X turns into protein Y , is denoted by a solid line with an
arrow. There are two types of modifiers that change the rate of a reaction,
catalysis and inhibition. Catalysis (increase in the rate of a reaction) is
denoted by a dashed line with an arrow. Inhibition (decrease in the rate of a
reaction) is denoted by a solid line with a blunt end. Finally, we distinguish
between inactive and active proteins rather than the various mechanisms by
which a protein changes state. An active protein is decorated with ∗. This
notation is illustrated in Figure 1a).
Reac%on	  
Catalysis	  
Inhibi%on	  
Protein	  
Ac%vated	  Protein	   *	  X	  
X	  
a)	  
X	   X	  
Y	   Y	  
*	  
*	  
b)	  
Figure 1: a) the notation used throughout this paper for arcs and nodes, b) an example
of a 2-stage signalling cascade in which the activated protein X catalyses the activation
of protein Y .
2.2. Temporal logics
In this section we give a brief overview of two temporal logics: the qual-
itative logic CTL (Computational Tree Logic) and the quantitative logic
CSL (Continuous Stochastic Logic). The latter is a quantitative extension
of the former with probabilities and timing. In both logics we refer to safety
properties (“bad” properties to be avoided) and liveness properties (“good”
properties that capture required functionality).
2.2.1. Computational Tree Logic
An Atomic Proposition (AP) is a formula in propositional logic that can
be evaluated to a boolean value for a state in a Markov chain. An AP may
compare combinations of variables in a Markov chain and constant values,
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using equalities and inequalities =, <, ≤, etc. The arithmetic operations
+, −, ∗ and / may be applied to any combination of variables and constant
values. Looking ahead to the PRISM model of a simple reaction introduced
in the next section in Figure 2, examples of APs are: (A > 0), (A > B +C),
and (A = 1).
A CTL formula φ is defined as follows:
φ ::= AP | ¬ φ | φ ∧ φ | φ ∨ φ | A X φ | E X φ | A φ U φ | E φ U φ |
A F φ | E F φ | A G φ | E G φ
where ¬, ∨ and ∧ denote “not,” “or” and “and” respectively.
Path operators:
Universal A all paths from the state
Existential E at least one path from the state
Temporal operators:
Next X φ φ holds in the next state
Until φ1 U φ2 φ1 holds in every state before φ2
Finally F φ φ holds in some future state
Globally G φ φ holds in every state
We also use the non-standard filter construct φ { ψ } as implemented by
PRISM. A filter allows a property φ to be checked from a state other than
the initial state of the Markov chain, in this case a state that satisfies ψ.
2.2.2. Continuous Stochastic Logic
In CSL the path operators A and E are replaced with the probability
operator P./x where x is the probability of the formula and ./ ∈ {>,≥, <,≤}.
Hence the operator A is equivalent to P≥1 and E to P>0. The probability
of the formula x can be returned in the PRISM model checker using P=?.
Furthermore, the temporal operators can have a time bound thus for the
Finally operator, F≤10 φ, expresses φ must become true within 10 time units.
2.3. Related work
There are several computational models of specific pathways that include
an aspect of cross-talk. For example, in [11, 12, 13], Ordinary Differential
Equations (ODEs) are used to model the cross-talk between the MAPK and
AKT pathways, the MAPK and PKC pathways, and the hyperosmolar and
the pheromone MAPK pathways respectively. The analysis depends on the
pathways involved. In [13] the motivation for modelling is to answer how the
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pathways maintain signal specificity, given shared common proteins. Two
models are proposed, one that contains mutual inhibition between pathways
to limit signal bleed-through and one that contains scaffold proteins. In
[12] the goal is to investigate whether cross-talk has an effect on bistability,
namely whether the signal switches from transient to sustained activation as
a consequence of varying the duration of the signal. Cross-talk is expressed
implicitly in computational models, i.e. it is part of the system of equations,
with no explicit reference to pathways or interactions between pathways.
Therefore, there is no direct way to reason about cross-talk, especially to
detect or classify the cross-talk.
Formal models are also employed. For example, Petri nets are used to
model apoptosis decision-making in the Fas-induced and mitochondrial DNA
damage pathways, and this includes the Bid controlled cross-talk between
them [14]. [15] contains a discrete, state-based model of the multiple modes
of intercellular cross-talk between the EGFR and LIN-12/Notch signalling
pathways, developed in the language of Reactive Modules. Model checking
is used to check the validity of the model and to generate new biological
insights. But, intercellular cross-talk is considered within a multi-cellular
model. This work bears little relation to intracellular cross-talk, indeed, it is
considered a misnomer within parts of the life science community. Our focus
is cross-talk in a single-cell model.
In general, it is difficult to draw any generic methods or techniques from
these specific models.
We are aware of only one paper, [1], that addresses a more generic con-
cept of pathway and cross-talk. Models in [1] are defined using the rewrite
rules of the κ calculus; the notion of a “story” corresponds to a pathway and
an “influence map” defines how rules can inhibit each other. Superposition
of an influence map with a pathway suggests ways in which a story’s ending
can be delayed or prevented (i.e. delay or prevent pathway output), this
can be interpreted as detecting cross-talk. The pathways of [1] are minimal
execution paths to a goal, and thus cannot be compared directly with the es-
tablished signalling pathways (as defined by biologists and used in biological
literature) that we consider. Nonetheless, we note that superposition (via
renaming and synchronisation) is also fundamental to our approach.
We note this paper extends a preliminary study in [16] in several ways, in-
cluding enhancements to the PRISM language and a more rigorous treatment
of pathways and types of cross-talk.
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3. Reagent-centric modelling
We adopt a reagent-centric approach [17] to modelling in which each of the
reagents in a reaction is mapped to a process, whose variation reflects increase
or decrease in amount of the reagent, through production or consumption.
We give a brief outline as follows.
As an example, the reaction r1 given in chemical notation by A+B
r1−→
C refers to three reagents and so it is modelled by three processes: A, B
and C, which are then composed in parallel, synchronising on the event
r1. After the event r1, C is increased and A and B are decreased. The
processes can model individuals (molecules) or populations (concentrations of
biochemical species); we assume the latter here, and an underlying semantics
of continuous-time Markov chain (CTMC) with levels [18].
Definition 1 (CTMC). Given a finite set of atomic propositions AP , a
continuous-time Markov chain (CTMC) is a triple C = (S,R, L) where S is
a finite set of states, R : S × S → R≥0 a rate matrix, and L : S → 2AP
a labelling of states. For a given state s, there is a race between outgoing
transitions from s if there is more than one state s′ such that R(s, s′) > 0.
The probability that a transition from s to s′ completes within t time units
when R(s, s′) > 0 is determined according to the distribution 1− e−R(s,s′)·t.
In a CTMC with levels, states are characterised by concentration ranges,
discretised uniformly into N levels with step size h, for each species. Note,
the choice of h applies to all species. Though, we can increase or decrease h
depending on the degree of granularity of the model that we require.2
Definition 2 (CTMC with levels). The states of a CTMC with levels are
vectors of levels s = ([A1], [A2], ..., [An]), where for i = 1, 2, ..., n, Ai is a
species, and [Ai] is the level of the species Ai. The transitions represent reac-
tions and each transition causes a change in the level number of one or more
species, the variation in the number of levels depending on the stoichiometry
of the reaction. With each reaction we associate characteristic species vec-
tors pre and post of size n for the set of reactants and the set of products
respectively. The reaction can be fired from a state s if s − pre ≥ 0 and
s− pre + post ≤ (N, . . . , N). If a transition from s is taken according to this
2Different choices of h for different species are possible, but only in very restricted
circumstances.
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reaction, the new state is s′ = s− pre + post. Assuming all species have the
same step size h, stoichiometry 1, and mass action kinetics, then the rate
associated with a transition from state u to state v, when the reactants of u
are [R1], [R2], ..., [Rm] is:
r∗[R1]∗h∗[R2]∗h...∗[Rm]∗h
h
.
3.1. Reagent-centric modelling in the PRISM modelling language
Reagent-centric modelling is implemented in a straight forward way in a
state-based formalism [4] such as the language of reactive modules [19] for the
PRISM model checker [20]. The PRISM language includes modules with local
variables and labelled transitions, multiway synchronisation between modules
and process algebraic operators. Each process is implemented by a module,
and modules are composed with multiway synchronisation on reaction names,
which are used to label transitions.
For example, the PRISM model for the reaction r1 above, i.e. A+B
r1−→
C, is in Figure 2. There are three modules: A, B and C, and a system
description stating that the three modules run concurrently. Each module
has the form: a state variable denoting the species concentration, followed
by transitions labelled by the reactions in which the species is a reagent.
In this case, there is a single transition labelled r1. The transition has the
form condition→ rate:assignment, meaning when the condition is true, then
perform the assignment at the given rate. The assignments in the first two
modules decrease the level by 1 and in the third module increase the level by
1. Initially, there are N levels of A and B and 0 levels of C. Since all three
transitions have the same label, they synchronise, and when they do, the
resulting transition occurs with a rate that is the product of the individual
rates, i.e. e1 ∗ e2 ∗ e3. The exact definition of the rate expressions depends
on the level of detail required in the model. For example, if we require mass
action kinetics, then we would define e1 = A ∗ h, e2 = B ∗ h, and e3 = r/h.
We note that for the purposes of this study we do not require exact mass
action kinetics in our models and we simply use the (multiplicative) identity
1 for all rate expressions.
Synchronisation, renaming and hiding. In general, synchronisation between
modules is parameterised by labels as follows. Given modules M1 and M2,
and set of labels L, M1 |[L]| M2 denotes the concurrent composition of
M1 and M2, synchronising on all labels in L. If the label set is omit-
ted, i.e. M1 || M2, then M1 synchronises with M2 on the intersection
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module A
A : [0..N] init N;
[r1] A > 0 -> e1:(A’ = A - 1);
endmodule
module B
B : [0..N] init N;
[r1] B > 0 -> e2:(B’ = B - 1);
endmodule
module C
C : [0..N] init 0;
[r1] C < N -> e3:(C’ = C + 1);
endmodule
system
A || B || C
endsystem
Figure 2: A reagent-centric model of A+B r1−→ C in PRISM.
of labels occurring in M1 and M2. PRISM also allows renaming of la-
bels, denoted thus M1 {old label ← new label}, and hiding, denoted thus
M \ {label1, . . . , labeln}. Hidden labels are not available for synchronisa-
tion.
3.2. PRISM language extensions
The PRISM modelling language does not include all the abstractions
required for generic modules. We therefore introduce two extensions to make
the language more convenient for modelling – they do not add any expressive
power to the language.
Variable Sharing. We require two or more modules to reference and update
the same variable. We cannot use a PRISM global variable for this purpose
because they cannot be updated within a labelled transition. So, we use
PRISM local variables and introduce new syntax as follows: M1 |[L, V ]|M2,
where V = {(v1, w1), . . . , (vn, wn)}. (vi, wi) is called a variable sharing where
vi (local to M1) and wi (local to M2) are shared. We implement a variable
10
sharing (vi, wi) in PRISM by a pre-processing step in which we substitute wi
for vi. For each command r in M1, we remove all references to vi from r and
define a new command r in M2, replacing vi with wi; we then synchronise M1
and M2 over r. We assume that the PRISM modules have the same number
of levels N for all variables and so the ranges of the shared variables are the
same. The initial value of the shared variable is max(init(vi), init(wi)) where
init(var) is the initial value of the variable var. Because we can now share
variables between two modules, we extend the hide operator to hide local
variables so that they are unavailable for sharing. Hence we can hide labels
and variables in a module thus M \ {label1, . . . , labeln, var1, . . . , varn}.
Synchronisation Within Modules. We will also require synchronisations in-
volving labelled transitions within the same module. For example, suppose
we have two labels r1 and r2 in module M1. Renaming one by the other will
not force a synchronisation. M1 {r2 ← r1} will create two r1 labels in M1,
and a non-deterministic choice between the labels. So, we simply assume an
alternative semantics for renaming when the labels are in the same module.
With the new semantics, our example M1 {r2 ← r1} means synchronise r1
and r2, which we implement by pre-processing (to form a single transition
r1 that is the conjunction of the transitions for r1 and r2).
4. Modelling a pathway
We define a generic pathway module to be a behavioural pattern within a
pathway. For example, commonly occurring pathway modules are: Receptor,
3-stage Cascade and Gene Expression (Figure 3).
The Receptor module has three species (L for ligand, R for receptor and
R∗ for active receptor) and two reactions (r1 and r2). The 3-stage Cascade
module has 3 species (proteins X, Y and Z) and 4 reactions (r3, r4, r5 and
r6). The Gene Expression module has 2 species (Gene and Protein) and one
reaction (r7). While Gene is not strictly a biochemical species, for modelling
purposes we treat it as a species. We use shading to indicate species with
initial concentrations (the species present in the initial state).
We represent the three generic pathway modules as PRISM modules with
N = 1 in Figure 4.3
3PRISM reserves certain names such as X and does not allow names with the ∗ symbol
– strictly we use names such as XInactive instead of X and XActive instead of X∗.
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3-­‐stage	  Cascade	  Receptor	  
Gene	  Expression	  
R	  
R	   L	  
*	  
r1	  
r2	  
X	   X	  
Y	   Y	  
Z	   Z	  
*	  
*	  
*	  
r4	  
r5	  
r3	  
r6	  Gene	   Protein	  r7	  
Figure 3: Three generic pathway modules: Receptor, 3-stage Cascade and Gene Expres-
sion.
We treat these modules as generic, that is, we instantiate them (strictly,
duplicate and rename in PRISM) for multiple occurrences. We adopt the
following convention. For generic module M , Mi denotes an instance of M
with every variable and reaction renamed by an indexed form. For example,
variable v becomes v1 in module M1.
We can compose modules synchronising over sets of labels as follows.
Synchronising reaction a in module A with b in module B is achieved by
renaming a to b and synchronising the modules over b, i.e. A {a← b} |[b]| B.
In this paper we use the term label and reaction synonymously.
A pathway is a parallel composition of instances of generic modules, re-
naming reactions to coordinate synchronisation within the pathway.
Definition 3 (Pathway). Let G be a set of generic modules. A pathway P
has the form (X1f1 |[L1]| . . . |[Ln−1]| Xnfn) \ H where X1 . . . Xn are
instances of modules in G, f1 . . . fn are sets of renamings, L1 . . . Ln−1 are
labels (reactions) and H is a set of hidings.
Definition 4 (Renaming pathway reactions). The reactions in a pathway
P can be renamed creating a new pathway P ′ = P {renamings} where
renamings is a set of renamings.
As an example, consider pathway Pathway1 comprising instances of the
Receptor, 3-stage Cascade and Gene Expression modules:
Pathway1 = (Receptor1 {r21 ← r31}
|[r31]|
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module Receptor
R : [0..1] init 1; L : [0..1] init 1; R* : [0..1] init 0;
[r1] R = 1 & L = 1 & R* = 0 -> 1:(R’ = 0) & (L’ = 0) & (R*’ = 1);
[r2] R* = 1 -> 1:true;
endmodule
module 3StageCascade
X : [0..1] init 1; X* : [0..1] init 0;
Y : [0..1] init 1; Y* : [0..1] init 0;
Z : [0..1] init 1; Z* : [0..1] init 0;
[r3] X = 1 & X* = 0 -> 1:(X’ = 0) & (X*’ = 1);
[r4] Y = 1 & Y* = 0 & X* = 1 -> 1:(Y’ = 0) & (Y*’ = 1);
[r5] Z = 1 & Z* = 0 & Y* = 1 -> 1:(Z’ = 0) & (Z*’ = 1);
[r6] Z* = 1 -> 1:true;
endmodule
module GeneExpression
Gene : [0..1] init 1; Protein : [0..1] init 0;
[r7] Gene = 1 & Protein = 0 -> 1:(Gene’ = 0) & (Protein’ = 1);
endmodule
Figure 4: The three generic modules in PRISM with N = 1.
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3StageCascade1 {r61 ← r71}
|[r71]|
GeneExpression1)
\ {r11, r31, r41, r51, R1, L1, R∗1, Gene1, P rotein1}
Receptor1 and 3StageCascade1 modules synchronise on r21 and r31, and
3StageCascade1 and GeneExpression1 synchronise on r61 and r71 (strictly,
we rename r21 to r31 and synchronise the modules on r31, and similarly for
r61 and r71). Because of these synchronisations, the active receptor catalyses
the activation of protein X and active protein Z catalyses the expression of
Gene. Reactions r11, r31, r41 and r51 and variables R1, L1, R
∗
1, Gene1 and
Protein1 are hidden using the \ operator.
Reactions and (local) variables are considered to be external or internal.
Definition 5 (External reactions and variables). For a pathway P , the set
of external reactions, extr(P ), is the set of reactions, modulo renamings, that
have not been hidden and the set of external variables, extv(P ), is the set of
(local) variables that have not been hidden. External reactions are available
for synchronisation and external variables are available for sharing.
Hence, extr(Pathway1) = {r71} and extv(Pathway1) = {X1, Y1, Z1, X∗1 ,
Y ∗1 , Z
∗
1}.
As a further example we define pathway Pathway2:
Pathway2 = (Receptor2 {r22 ← r32}
|[r32]|
3StageCascade2 {r62 ← r72}
|[r72]|
GeneExpression2)
\ {r12, r32, r42, r52, R2, L2, R∗2, Gene2, P rotein2}
With extr(Pathway2) = {r72} and extv(Pathway2) = {X2, Y2, Z2, X∗2 ,
Y ∗2 , Z
∗
2}.
Pathways Pathway1 and Pathway2 are shown graphically in Figure 5.
We now consider networks of pathways.
5. Modelling a network of independent pathways
Here we give the general definition of a network, and then consider the
special case of networks of independent pathways. Later we consider networks
with cross-talk.
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r71	  
*	  
Gene1	   Protein1	  
*	  
*	  
r41	  
r51	  
r31	  X1	   X1	  
Y1	  
Z1	   Z1	  
Y1	  
*	  
*	  
*	  
r42	  
r52	  
r32	  X2	   X2	  
Y2	  
Z2	   Z2	  
Y2	  
r72	  Gene2	   Protein2	  
*	  
r11	  
R1	   L1	  
R1	   *	  
r12	  
R2	   L2	  
R2	  
Pathway1	   Pathway2	  
Figure 5: The two pathways Pathway1 and Pathway2 each comprise three instances of
the generic pathway modules Receptor, 3-stage Cascade and Gene Expression. External
reactions and variables are denoted by black lines, internal reactions and variables by grey
lines and species that are present in the initial state by shaded ellipses.
A network is a parallel composition of pathways, with optional synchro-
nisation of external reactions and sharing of variables between pathways.
Definition 6 (Network). A network is a composition of two pathways of the
form P1 {renamings1} |[E ∪ U, V ]| P2 {renamings2} where |[E ∪ U, V ]|
defines the interaction between P1 and P2. renamings1 and renamings2
are optional sets of renamings of reactions. E = extr(P1 {renamings1}) ∩
extr(P2 {renamings2}), in other words, E is the intersection of the sets of ex-
ternal reactions, modulo renamings, in P1 and P2. V is a set of variable shar-
ings between P1 and P2. U ⊆ extr(P1 {renamings1}) ∪ extr(P2 {renamings2
}).
Note, P1, P2, renamings1, renamings2, U and V determine the network.
Now consider the special case of a network of independent pathways.
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Definition 7 (Independent pathways). A network of two pathways
P1 {renamings1} |[E ∪ U, V ]| P2 {renamings2} is independent if there is no
synchronisation of reactions and sharing of variables between the pathways,
hence E = ∅ and V = ∅.
We can compose our two example pathways independently thus:
Pathway1 |[E ∪ U, V ]| Pathway2 where E = V = U = ∅.
We now turn our attention to the case where there is synchronisation of
reactions or sharing of variables between the pathways, i.e. there is cross-talk.
However, before doing so we introduce the concept of auxiliary reactions, and
ultimately how they result in unused reactions, i.e. the set U .
6. Auxiliary reactions
Auxiliary reactions are additional basic reactions and modifiers that can
be used to express interactions between pathways.
Definition 8 (Auxiliary reactions). There are four types of auxiliary reac-
tions for a species X as given in Figure 6.
Produc'on	  
∅	  Degrada'on	  
∅	  X	  
X	  
Reac'ons	   Modiﬁers	  
Catalysis	  
Inhibi3on	  
X	  
X	  
Figure 6: The four types of auxiliary reactions, two are reactions and two are modifiers.
Production and degradation reactions are the two basic reactions for any
species. All other reactions can be defined by synchronising production and
degradation reactions. For example, we can express the formation of Z from
X and Y by synchronising the degradation of X and Y with the production
of Z.
Catalysis and inhibition are modifiers: they change the (PRISM) condi-
tion of reactions. Catalysis and inhibition auxiliary reactions must synchro-
nise with a reaction to make (biological) sense.
For any species X we can add any number of any type of auxiliary reac-
tions.
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r42	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Z2	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*	   ∅	  
r11	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   L1	  
R1	  
∅	  
∅	  
a21	  
∅	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  ∅	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  a62	  
*	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R2	   L2	  
R2	  
a12	  
∅	  
∅	  
a22	  
∅	  
a32	  
Pathway2	  
Figure 7: The two pathways Pathway1 and Pathway2 with added auxiliary reactions.
Definition 9 (PRISM implementation). For any species X in a module, for
any i, any of the 4 types of auxiliary reactions can be added as follows:
[prod_i] X = 0 -> 1:(X’ = 1);
[deg_i] X = 1 -> 1:(X’ = 0);
[cat_i] X = 1 -> 1:true;
[inhib_i] X = 0 -> 1:true;
Note, although we have not defined an explicit syntax for adding auxiliary
reactions, we assume for any given pathway P we can augment it with a given
set of auxiliary reactions aux(P ). For a pathway P there is an infinite number
of augmentations of auxiliary reactions.
Definition 10 (Pathway auxiliary reactions). For a given pathway P , the set
of auxiliary reactions is aux(P ) and we extend extr(P ) to include aux(P ),
i.e. all auxiliary reactions are external.
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We add to our two example pathways some auxiliary reactions, the mo-
tivation for these will be given in the next section.
We adopt the following convention. In Pathwayj we label auxiliary reac-
tion i as aij (or ai j in PRISM).
In the Receptor module in Pathwayj we add:
[a1_j] R = 1 -> 1:(R’=0);
[a2_j] R* = 0 -> 1:(R*’ = 1);
[a3_j] L = 0 -> 1:(L’ = 1);
In the 3-stage Cascade module in Pathwayj we add:
[a4_j] X* = 1 -> 1:true;
[a5_j] Y = 1 -> 1:(Y’=0);
[a6_j] Y* = 0 -> 1:(Y*’=1);
[a7_j] Z* = 0 -> 1:true;
In the Gene Expression module in Pathwayj we add:
[a8_j] Protein = 1 -> 1:(Protein’ = 0);
The pathways with added auxiliary reactions are shown graphically in
Figure 7.
Auxiliary reactions are an integral part of modelling cross-talk. We model
cross-talk by different combinations of synchronisation of external reactions
(which includes the auxiliary reactions) and sharing of variables.
Definition 11 (Cross-talk). Given a network of two pathways
P1 {renamings1} |[E ∪ U, V ]| P2 {renamings2}, there is cross-talk if
there is at least one reaction e ∈ E or one variable sharing v ∈ V . The
number of cross-talks is |E|+ |V |.
We now introduce the concept of unused reactions U with the aid of the
following functions.
Definition 12 (Mapped). Given a network of two pathways
P1 {renamings1} |[E ∪ U, V ]| P2 {renamings2}, for any e ∈ E, we define
the function mapped(e) = {xi|xi ← e} ∪ {ui|ui ← e} where renamings1 =
{x1 ← y1, . . . , xn ← yn} and renamings2 = {u1 ← v1, . . . , un ← vn}. We
also define mapped(E) =
⋃
e∈Emapped(e). In other words, mapped(e) is
the set of reactions involved in one synchronisation e between the pathways
and mapped(E) is the set of reactions involved in any synchronisation e ∈ E
between the pathways.
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The unused reactions U are the auxiliary reactions that are not used for
synchronisation between two pathways, and so U = (aux(P1) ∪ aux(P2)) \
mapped(E). Note that since each reaction in U occurs in only one pathway,
they cannot synchronise and their corresponding transitions never execute.
This will be explored in detail in the next section, where we turn our attention
to a network of two pathways in which there is cross-talk.
7. Categorisation of cross-talk
Although there is some discussion of types of cross-talk [21], there appears
to be no universal categorisation in the literature. In this section we propose
that there are five types of cross-talk: substrate availability, signal flow,
receptor function, gene expression and intracellular communication. We note
that four of the five types are alluded to in [22] but are not made specific.
We give the motivation for the five types using indicative examples from
the literature. We define several functions that are used in the formalisation.
We then formalise the types and prove that the types are distinct. Finally,
we give examples of each type of cross-talk using our example pathways
Pathway1 and Pathway2.
7.1. Motivation for types
In this section we give evidence of each of the five types. While there is
no proof that there are no other types of cross-talk, we have found no ex-
amples after performing an exhaustive literature search and discussing this
with domain experts.
Substrate availability cross-talk In [13] there are two pathways that
compete for activation of the MAPK cascade. The pathways share the MAP-
KKK protein STE11 and have homologous MAPKK and MAPK proteins.
Signal flow cross-talk In [10] there is signal flow cross-talk between the
MAPK and Integrin signalling pathways. Activation of the Integrin pathway
enhances signalling through the MAPK pathway by increased rate of activa-
tion of key proteins in the pathway.
Receptor function cross-talk In [23] other signalling pathways can
activate the Estrogen receptor in the absence of the Estrogen ligand.
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Gene expression cross-talk In [24] two pathways contain cross-talk
within the nucleus. One pathway contains a transcription factor GR that
resides outside the nucleus. Upon signalling, GR relocates to the nucleus
and represses the transcription factor NF-κB that is activated by another
pathway.
Intracellular communication cross-talk In [21] the TGF-β and WNT
pathways reciprocally regulate the production of their ligands. There is some
contention in the literature as to whether this is genuine cross-talk: the in-
teraction is less direct than other types of cross-talk and involves lengthy
processes such as gene expression and ligand excretion.
We now turn to formalising the 5 types, but before doing so, we define
several useful functions on the generic modules.
7.2. Functions on modules
We define several functions that operate on modules, of type
func : Module→ {Labels}.
all – all reactions
all(Receptor) = {a1, a2, a3, r1}
all(3StageCascade) = {a4, a5, a6, a7, r3, r4, r5}
all(GeneExpression) = {a8, r7}
trans – all transformation reactions
trans(Receptor) = {a1, a2, a3, r1}
trans(3StageCascade) = {a5, a6, r3, r4, r5}
trans(GeneExpression) = {a8, r7}
mod – all modifiers
mod(Receptor) = ∅
mod(3StageCascade) = {a4, a7}
mod(GeneExpression) = ∅
Note that ∀x.all(x) = trans(x) ∪mod(x).
catalysis – all catalysis reactions
catalysis(Receptor) = ∅
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catalysis(3StageCascade) = {a4}
catalysis(GeneExpression) = ∅
inhib – all inhibition reactions
inhib(Receptor) = ∅
inhib(3StageCascade) = {a7}
inhib(GeneExpression) = ∅
prod – all production reactions
prod(Receptor) = {a2, a3}
prod(3StageCascade) = {a6}
prod(GeneExpression) = ∅
deg – all degradation reactions
deg(Receptor) = {a1}
deg(3StageCascade) = {a5}
deg(GeneExpression) = {a8}
receptor deg – all degradation of (inactive) receptor reactions
receptor deg(Receptor) = {a1}
receptor deg(3StageCascade) = ∅
receptor deg(GeneExpression) = ∅
receptor act – all ligand-receptor binding reactions
receptor act(Receptor) = {r1}
receptor act(3StageCascade) = ∅
receptor act(GeneExpression) = ∅
active receptor prod – all production of active receptor reactions
active receptor prod(Receptor) = {a2}
active receptor prod(3StageCascade) = ∅
active receptor prod(GeneExpression) = ∅
ligand prod – all production of ligand reactions
ligand prod(Receptor) = {a3}
ligand prod(3StageCascade) = ∅
ligand prod(GeneExpression) = ∅
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gene expression – all gene expression reactions
gene expression(Receptor) = ∅
gene expression(3StageCascade) = ∅
gene expression(GeneExpression) = {r7}
7.3. Cross-talk types
We now formalise the 5 types of cross-talk: substrate availability, signal
flow, receptor function, gene expression and intracellular communication, in
terms of the three modules introduced so far. Extending the formalisation
to include extra modules that behave in a similar way is trivial.
Given a network of the form P1 {renamings1} |[E ∪ U, V ]|
P2 {renamings2}, a cross-talk is either a e ∈ E or a v ∈ V .
A cross-talk v ∈ V is always substrate availability cross-talk.
A cross-talk e ∈ E is categorised according to the rules below. Rules
are either necessary rules or biological constraints. Biological constraints
prevent infeasible cross-talk due to, for example, different cellular locations
or different species types. These constraints concern which reactions can
be synchronised between two pathways, thus a constraint always concerns
members of mapped(e).
We use the notation Module Type ∈ Pi to mean a module in Pi of type
Module Type. The operator ∃!x.f(x) is defined by ∃x.(f(x) ∧ ∀y.(f(y) →
y = x))
Finally, we note by the definition of E in a network the following prop-
erties hold.
• ∀e ∈ E.∀x ∈ mapped(e).(x ∈ P1 ∨ x ∈ P2)
• ∀e ∈ E.∃x ∈ mapped(e).(x ∈ P1)
• ∀e ∈ E.∃x ∈ mapped(e).(x ∈ P2)
Signal flow cross-talk
e is signal flow cross-talk if and only if the rules in Case 1 or Case 2 hold.
Case 1: P1 affects a transformation reaction in P2 or vice-versa.
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Rules
∃x ∈ mapped(e).∃3StageCascade ∈ (P1 ∪ P2).x ∈ trans(3StageCascade)
Biological constraints
∀x ∈ mapped(e).∀Receptor ∈ (P1 ∪ P2).x 6∈ trans(Receptor)
∀x ∈ mapped(e).∀GeneExpression ∈ (P1 ∪ P2).x 6∈ all(GeneExpression)
Case 2: P1 produces a protein in P2 or vice-versa, or else P2 catalyses
P1’s production of a protein, or vice-versa, or P2 inhibits P1 from producing
a protein, or vice-versa.
Rules
∃!x ∈ mapped(e).∃GeneExpression ∈ (P1 ∪ P2).x ∈ deg(GeneExpression)
∃!x ∈ mapped(e).∃3StageCascade ∈ (P1 ∪ P2).x ∈ prod(3StageCascade)
Biological constraints
∀x ∈ mapped(e).∀Receptor ∈ (P1 ∪ P2).x 6∈ all(Receptor)
∀x ∈ mapped(e).∀3StageCascade ∈ (P1 ∪ P2).x ∈ trans(3StageCascade)
→ x ∈ prod(3StageCascade)
∀x ∈ mapped(e).∀GeneExpression ∈ (P1 ∪ P2).x ∈ all(GeneExpression)
→ x ∈ deg(GeneExpression)
Receptor function cross-talk
e is receptor function cross-talk if and only if the rules in Case 1, Case 2
or Case 3 hold.
Case 1: P1 catalyses P2’s receptor degradation, or vice-versa, with possi-
ble modifiers from 3-stage cascades.
Rules
∃!x ∈ mapped(e).∃Receptor ∈ Pi.x ∈ receptor deg(Receptor)
∃x ∈ mapped(e).∃3StageCascade ∈ Pj.x ∈ catalysis(3StageCascade)
where i 6= j
Biological constraints
∀x ∈ mapped(e).∀GeneExpression ∈ (P1 ∪ P2).x 6∈ all(GeneExpression)
∀x ∈ mapped(e).∀3StageCascade ∈ (P1 ∪ P2).x 6∈ trans(3StageCascade)
∀x ∈ mapped(e).∀Receptor ∈ (P1 ∪ P2).x ∈ all(Receptor)
→ x ∈ receptor deg(Receptor)
Case 2: The activation of P1’s receptor is inhibited by P2, or vice-versa,
with possible extra modifiers from 3-stage cascades.
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Rules
∃!x ∈ mapped(e).∃Receptor ∈ Pi.x ∈ receptor act(Receptor)
∃x ∈ mapped(e).∃3StageCascade ∈ Pj.x ∈ inhib(3StageCascade)
where i 6= j
Biological constraints
∀x ∈ mapped(e).∀GeneExpression ∈ (P1 ∪ P2).x 6∈ all(GeneExpression)
∀x ∈ mapped(e).∀3StageCascade ∈ (P1 ∪ P2).x 6∈ trans(3StageCascade)
∀x ∈ mapped(e).∀Receptor ∈ (P1 ∪ P2).x ∈ all(Receptor)
→ x ∈ receptor act(Receptor)
Case 3: P1’s receptor is activated without the need for a ligand and this
is catalysed by P2, or vice-versa, with possible extra modifiers from 3-stage
cascades.
Rules
∃!x ∈ mapped(e).∃Receptor ∈ Pi.x ∈ receptor deg(Receptor)
∃!x ∈ mapped(e).∃Receptor ∈ Pi.x ∈ active receptor prod(Receptor)
∃x ∈ mapped(e).∃3StageCascade ∈ Pj.x ∈ catalysis(3StageCascade)
where i 6= j
Biological constraints
∀x ∈ mapped(e).∀3StageCascade ∈ (P1 ∪ P2).x 6∈ trans(3StageCascade)
∀x ∈ mapped(e).∀GeneExpression ∈ (P1 ∪ P2).x 6∈ all(GeneExpression)
∀x ∈ mapped(e).∀Receptor ∈ (P1 ∪ P2).x ∈ all(Receptor)
→ (x ∈ receptor deg(Receptor) ∨ x ∈ active receptor prod(Receptor))
Gene expression cross-talk
The rate of P1’s gene expression reaction is modified by a species in a
3-stage cascade module in P2 or vice-versa.
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Rules
∃!x ∈ mapped(e).∃GeneExpression ∈ (P1 ∪ P2).
x ∈ gene expression(GeneExpression)
∃x ∈ mapped(e).∃3StageCascade ∈ (P1 ∪ P2).x ∈ mod(3StageCascade)
Biological constraints
∀x ∈ mapped(e).∀Receptor ∈ (P1 ∪ P2).x 6∈ all(Receptor)
∀x ∈ mapped(e).∀3StageCascade ∈ (P1 ∪ P2).x 6∈ trans(3StageCascade)
∀x ∈ mapped(e).∀GeneExpression ∈ (P1 ∪ P2).x ∈ all(GeneExpression)
→ x ∈ gene expression(GeneExpression)
Intracellular Communication cross-talk
A protein is released from P1 that is the ligand for P2, or vice-versa, with
possible extra modifiers from 3-stage cascades.
Rules
(∃!x ∈ mapped(e).∃GeneExpression ∈ Pi.x ∈ deg(GeneExpression))∨
(∃!x ∈ mapped(e).∃3StageCascade ∈ Pi.x ∈ deg(3StageCascade))
∃x ∈ mapped(e).∃Receptor ∈ Pj.x ∈ ligand prod(Receptor)
where i 6= j
Biological constraints
∀x ∈ mapped(e).∀GeneExpression ∈ (P1 ∪ P2).x ∈ all(GeneExpression)
→ x ∈ deg(GeneExpression)
∀x ∈ mapped(e).∀3StageCascade ∈ (P1 ∪ P2).x ∈ trans(3StageCascade)
→ x ∈ deg(3StageCascade)
∀x ∈ mapped(e).∀Receptor ∈ (P1 ∪ P2).x ∈ all(Receptor)
→ x ∈ ligand prod(Receptor)
7.4. Categorisation is well-defined
We prove below that the categorisation is well-defined, i.e. that any
cross-talk that has been categorised has only one type.
Theorem 1. Categorisation is well-defined.
Proof. Trivially, any cross-talk v is of type substrate availability cross-talk.
We now in turn assume a cross-talk e of each type and give a witness,
a label that must/must not be part of the cross-talk, that prevents it from
being another type of cross-talk.
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Suppose e has been categorised as signal flow cross-talk. In both cases of
signal flow cross-talk, no transformation reactions from a Receptor module
are allowed in mapped(e), hence x ∈ {a1, a2, a3, r1} → x 6∈ mapped(e).
A receptor function cross-talk must have a label from
receptor deg(Receptor) (Case 1 and Case 3) or a label from
receptor act(Receptor) (Case 2). Therefore, a1 ∈ mapped(e) ∨ r1 ∈
mapped(e).
The witness to e not being a receptor function cross-talk is a1 6∈ mapped(e)
and r1 6∈ mapped(e).
Assuming e is each type of cross-talk in turn, we list below the witnesses
that prove e can have no other type.
e is signal flow cross-talk Witness
cannot be receptor function ∀x ∈ {a1, r1}.x 6∈ mapped(e)
cannot be gene expression r7 6∈ mapped(e)
cannot be intracellular communication a3 6∈ mapped(e)
e is receptor function cross-talk Witness
cannot be signal flow ∀x ∈ {a5, a6, r3, r4, r5}.
x 6∈ mapped(e)
cannot be gene expression r7 6∈ mapped(e)
cannot be intracellular communication a3 6∈ mapped(e)
e is gene expression cross-talk Witness
cannot be signal flow ∀x ∈ {a5, a6, r3, r4, r5}.
x 6∈ mapped(e)
cannot be receptor function ∀x ∈ {a1, r1}.x 6∈ mapped(e)
cannot be intracellular communication a3 6∈ mapped(e)
e is intracellular communication cross-talk Witness
cannot be signal flow a3 ∈ mapped(e)
cannot be receptor function ∀x ∈ {a1, r1}.x 6∈ mapped(e)
cannot be gene expression r7 6∈ mapped(e)
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7.5. Examples of cross-talk
Given two pathways, we can generate all possible instances of cross-talk;
the algorithm is given in Appendix A, it depends upon k, the maximum
number of synchronisations on a reaction. Applying the algorithm to our
two example pathways, Pathway1 and Pathway2, with k = 3, yields 757
candidate examples of cross-talk (that do not necessarily satisfy the biological
constraints) and 175 actual examples of cross-talk. The latter are categorised
as follows: 36 substrate availability, 65 signal flow, 18 receptor function, 28
gene expression, and 28 intracellular communication. Below, we give an
example from each type.
Substrate availability cross-talk The pathways compete for activation
of protein X, hence the pathways share variables X1 and X2.
Pathway1 |[E ∪ U, V ]| Pathway2
where U = aux(Pathway1) ∪ aux(Pathway2), E = ∅ and V = {(X1, X2)}.
This example is shown in Figure 8(a).
Signal flow cross-talk An alternative reaction to activate Y1 through
the X∗2 enzyme. Synchronise a51, the degradation of Y1, with a61, the pro-
duction of Y ∗1 to create the reaction
4 Y1 → Y ∗1 , and also synchronise with
a42, the enzymatic activity of X
∗
2 .
Pathway1 {a51 ← rnew, a61 ← rnew} |[E ∪ U, V ]| Pathway2 {a42 ← rnew}
where U = aux(Pathway1) ∪ aux(Pathway2) \ {a51, a61, a42}, E =
{rnew} and V = ∅. This example is shown in Figure 8(b).
Receptor function cross-talk An alternative reaction to activate re-
ceptor R2 by the enzyme X
∗
1 . Synchronise a12, the degradation of receptor
R2, with a22, the production of the active receptor R
∗
2 to create the reaction
R2 → R∗2, and also synchronise a41, the enzymatic activity of X∗1 .
Pathway1 {a41 ← rnew} |[E ∪ U, V ]| Pathway2 {a12 ← rnew, a22 ← rnew}
where U = aux(Pathway1) ∪ aux(Pathway2) \ {a41, a12, a22}, E =
{rnew} and V = ∅. This example is shown in Figure 8(c).
Gene expression cross-talk Inhibit the expression of Gene1 by the
Z∗2 protein. Synchronise a72, the inhibiting activity of Z
∗
2 , with r71, the
expression of Gene1.
4notice that this is synchronisation within a module
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Pathway1 {r71 ← rnew} |[E ∪ U, V ]| Pathway2 {a72 ← rnew}
where U = aux(Pathway1) ∪ aux(Pathway2) \ {a72, r71}, E = {rnew}
and V = ∅. This example is shown in Figure 8(d).
Intracellular communication cross-talk The output of expressing
Gene1 is the ligand for Pathway2. Synchronise a81, the degradation of
Protein1, with a32, the production of the ligand L2 to create the reaction
Protein1 → L2.
Pathway1 {a81 ← rnew} |[E ∪ U, V ]| Pathway2 {a32 ← rnew}
where U = aux(Pathway1) ∪ aux(Pathway2) \ {a81, a32}, E = {rnew}
and V = ∅. This example is shown in Figure 8(e).
7.6. Higher order networks
We have defined how to model networks of two pathways. Higher order
networks can be modelled by composing a network with a single pathway,
hence:
Network2 = Pathway1 |[E1 ∪ U1, V1]| Pathway2
Network3 = Network2 |[E2 ∪ U2, V2]| Pathway3
. . .
Networki = Networki−1 |[Ei−1 ∪ Ui−1, Vi−1]| Pathwayi
However, to the best of our knowledge all cross-talk are between pairs
of pathways. Our definition of a network allows a single cross-talk in which
three or more pathways participate, however no biological examples of such
an interaction have been reported.
This concludes modelling cross-talk. We now switch our focus from defin-
ing and categorising cross-talk in a rigorous way to analysing models of cross-
talk using logical properties.
8. Detecting cross-talk
So far we have discussed the main contribution of this paper, how to model
cross-talk in a rigorous way by looking at the form of the model description,
e.g. the synchronisations between PRISM modules. We now give preliminary
results on the complementary problem, how to analyse at the model level (i.e.
28
*	  
Gene1	   Protein1	  
*	  
*	  
X	  
X1	  
Y1	  
Z1	   Z1	  
Y1	  
*	  
*	  
*	  
X2	  
Y2	  
Z2	   Z2	  
Y2	  
Gene2	   Protein2	  
*	  
R1	   L1	  
R1	   *	  
R2	   L2	  
R2	  
a)	  	  Substrate	  Availability	  
*	  
Gene1	   Protein1	  
*	  
*	  
X1	   X1	  
Y1	  
Z1	   Z1	  
Y1	  
*	  
*	  
*	  
X2	   X2	  
Y2	  
Z2	   Z2	  
Y2	  
Gene2	   Protein2	  
*	  
R1	   L1	  
R1	   *	  
R2	   L2	  
R2	  
b)	  	  Signal	  Flow	  
*	  
Gene1	   Protein1	  
*	  
*	  
X1	   X1	  
Y1	  
Z1	   Z1	  
Y1	  
*	  
*	  
*	  
X2	   X2	  
Y2	  
Z2	   Z2	  
Y2	  
Gene2	   Protein2	  
*	  
R1	   L1	  
R1	   *	  
R2	   L2	  
R2	  
c)	  	  Receptor	  Func7on	  
*	  
Gene1	   Protein1	  
*	  
*	  
X1	   X1	  
Y1	  
Z1	   Z1	  
Y1	  
*	  
*	  
*	  
X2	   X2	  
Y2	  
Z2	   Z2	  
Y2	  
Gene2	   Protein2	  
*	  
R1	   L1	  
R1	   *	  
R2	   L2	  
R2	  
d)	  	  Gene	  Expression	  
*	  
Gene1	   Protein1	  
*	  
*	  
X1	   X1	  
Y1	  
Z1	   Z1	  
Y1	  
*	  
*	  
*	  
X2	   X2	  
Y2	  
Z2	   Z2	  
Y2	  
Gene2	   Protein2	  
*	  
R1	   L1	  
R1	   *	  
R2	   L2	  
R2	  
e)	  	  Intracellular	  Communica:on	  
Figure 8: An example of each of the five types of cross-talk: a) two pathways compete for
a protein, b) a pathway up-regulates signal flow through another pathway, c) a pathway
activates the receptor of another pathway in the absence of a ligand, d) two pathways have
conflicting transcriptional responses, e) a pathway releases a ligand for another pathway.
29
at the level of the CTMC rather than the form of the model description5).
We aim to both detect and characterise cross-talk, we first tackle detecting
cross-talk in these models.
This section makes use of the two pathways Pathway1 and Pathway2
introduced in Section 4 and the five example cross-talk models of Section
7.5.
The presence of cross-talk can be detected by checking a set of temporal
logic properties as follows.
We choose CSL because we need a quantitative logic – it is a change in the
probability of a formula being true that allows us to detect the presence of a
cross-talk. The probabilities are used to measure the number of paths that
satisfy a property. For example, in the signal flow cross-talk example (com-
pared to the independent model) there is a greater number of paths to the
expression of Protein1. There are other ways to detect cross-talk, however
we use model checking of CSL properties as it is relatively straightforward
and familiar to a large part of the community.
Given pathways Pathway1 and Pathway2 that conclude with gene ex-
pression (Protein1 and Protein2 being produced respectively), we detect
cross-talk by comparing the probabilities of the following three CSL for-
mulae with the probability of independent composition. Namely, we com-
pare probabilities for the five example cross-talk models of Section 7.5 with
Pathway1 {renamings1} |[E ∪ U, V ]| Pathway2 {renamings2} where E = ∅
and V = ∅. In each case, cross-talk is indicated by a change of probability
of at least one formula.
Competitive Signal Flow (Pathway1 before Pathway2): probability of
signal flow through Pathway1 before Pathway2
ψ1 = P=? [ F (Protein1 = 1 ∧ Protein2 = 0) ]
Independent Signal Flow (Pathway1): probability of signal flow through
Pathway1 within a time bound (3 time units)
ψ2 = P=? [ F≤3 (Protein1 = 1) ]
Independent Signal Flow (Pathway2): probability of signal flow through
Pathway2 within a time bound (3 time units)
5for example, we define CTMCs in PRISM using the PRISM language whereas in a
tool like Matlab, we would define them with equations
30
ψ1 ψ2 ψ3
Substrate Availability Example = ↓ ↓
Signal Flow Example ↑ ↑ =
Receptor Function Example ↓ = ↑
Gene Expression Example ↓ ↓ =
Intracellular Communication Example = = =
Table 1: The change in probability for each of the 5 cross-talk models compared with the
independent pathways model for the three CSL properties.
ψ3 = P=? [ F≤3 (Protein2 = 1) ]
The change in probability for each of the 5 cross-talk models, as compared
to the independent pathways, is given in Table 1. ↑ denotes an increase, ↓
denotes a decrease and = denotes no change in probability. Results were
obtained using the PRISM model checker (run times are negligible).
Notice that there is no change in probability for the intracellular com-
munication cross-talk model. In our qualitative model of this cross-talk, one
pathway produces a ligand for another pathway only after the original ligand
molecule has been consumed in a reaction. This means that the cross-talk
has no effect on the rate of the activation reactions in either pathway. In a
model with a greater level of quantitative detail, as discussed in Section 11,
this cross-talk would change the rate of the activation reactions. This result
is not unexpected as we have already identified that intracellular communi-
cation cross-talk is a source of contention in the literature.
We now move on to characterising cross-talk in models in which there is
no model description.
9. Characterising cross-talk
The type of cross-talk can be characterised at the model level using dif-
ferent temporal logic properties.
We choose CTL because we need a qualitative logic – it is a difference in
the structure of the Markov chain rather than the transition rates that allows
us to distinguish between types of cross-talks. We define 5 CTL properties,
each of which characterises a type of cross-talk. The properties are simple
liveness or safety properties and do not exploit the rate information in the
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model.
As before, the activation of a pathway is reflected by the expression of
Protein. This is checked by evaluating the proposition (Protein = 1).
Substrate Availability Example (Pathway1 and Pathway2 compete for a pro-
tein). It is not possible to activate X in both pathways (i.e. the pathways
compete for a limited protein).
A G ¬ (X∗1 = 1 ∧ X∗2 = 1)
Signal Flow Example (flow from Pathway2 to Pathway1). It is possible to
activate Pathway1 without activating receptor R1.
E F (R∗1 = 0 ∧ Protein1 = 1)
Receptor Function Example (Pathway1 activates Pathway2’s receptor). It is
possible to activate the receptor R2 without using the ligand L2.
6
E F (R∗1 = 0 ∧ R∗2 = 1 ∧ L2 = 1)
Gene Expression Example (Pathway2 inhibits Pathway1’s gene expression).
It is not possible to activate Pathway1 if the signal has already passed
through Pathway2.
A G ¬ (Protein1 = 1) {Y ∗1 = 1 ∧ Z∗1 = 0 ∧ Protein∗2 = 1}
Intracellular Communication Example (Pathway1 expresses Pathway2’s lig-
and). It is possible to use and replenish ligand L2.
E (L2 = 1) U ( (L2 = 0) ∧ E (L2 = 0) U (L2 = 1) )
We now demonstrate our approach on a prominent case-study of the
cross-talk between the TGF-β, WNT and MAPK pathways.
10. Case-study
We apply our approach to a prominent biological case-study of the cross-
talk between the TGF-β, WNT and MAPK pathways. Details are taken from
[21] and from discussions with a domain expert [25]. We use the approach
to classify the cross-talk in the model and to understand the effects of the
cross-talk on the TGF-β pathway. We note that the effects of cross-talk are
not discussed in [21].
6We include R∗1 = 0 because signalling in Pathway1 in the intracellular communication
model can produce L2.
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Our model of the pathways and their cross-talk is shown in Figure 9. To
apply our modelling approach we need to expand our set of modules to: Re-
ceptor, Protein Activation, 2-stage Cascade, 3-stage Cascade, Translocation,
Protein Binding and Gene Expression. This is a natural extension of our
approach. The extra modules act in a similar manner to the modules that
have been discussed and so the extension of the formalisation from Section
7.3 is trivial.
We define the following three pathways (for brevity, we omit the synchro-
nisation sets and renamings).
MAPK = (Receptor {. . .} |[. . .]| ProteinActivation {. . .} |[. . .]|
Cascade3 {. . .} |[. . .]| Cascade2 {. . .} |[. . .]|
Translocation {. . .} |[. . .]| Translocation)
TGFB = (Receptor {. . .} |[. . .]| ProteinActivation {. . .} |[. . .]|
ProteinActivation {. . .} |[. . .]| ProteinBinding {. . .}
|[. . .]| Translocation {. . .} |[. . .]| GeneExpression {. . .}
|[. . .]| GeneExpression)
WNT = (Receptor {. . .} |[. . .]| ProteinActivation {. . .} |[. . .]|
Translocation {. . .} |[. . .]| GeneExpression)
As indicated in Figure 9, the following auxiliary reactions are added.
In the MAPK pathway we add catalysis auxiliary reactions to the MAPK∗,
AKT∗ and TF∗ species. In the TGF-β pathway we add degradation auxiliary
reactions to the Smad4 and Smad7 species. In the WNT pathway we add
catalysis auxiliary reactions to the Axin and β-Catenin∗ species.
We then consider four networks, TGFB, TGFB |[. . .]| MAPK, TGFB
|[. . .]| WNT and (TGFB |[. . .]| MAPK) |[. . .]| WNT , referred to as the full
network.
We detect the presence of 9 cross-talks in the full network using the
approach outlined in Section 9 – no new cross-talks are identified compared
with the literature. We then characterise each cross-talk using the approach
outlined in Section 8 and find that there are three types of cross-talk in the
model, as follows.
We measure the output of the TGF-β pathway by the activity of the
expression of Proteins (a set of proteins in the TGF-β pathway). We use
the following CSL properties to compare the effects of cross-talk: ψ1, the
eventual expression of Proteins, and ψ2, the time-dependent expression of
Proteins (within 5 time units).
ψ1 = P=? [ F (Proteins = 1) ]
ψ2 = P=? [ F≤5 (Proteins = 1) ]
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Figure 9: Cross-talk between the TGF-β, WNT and MAPK pathways. Species that are
present in the initial state are denoted by shaded ellipses.
We follow with a detailed analysis of each of the four networks.
Independent Network. In the independent network, TGFB, the activation of
the TGF-β pathway leads to the expression of Proteins within 5 time units,
ψ2, with probability 0.47 and to the eventual expression of Proteins, ψ1, with
probability < 1 due to the inactivation of the receptor.
TGF-β and MAPK Cross-talk. In the TGF-β and MAPK network, TGFB
|[. . .]| MAPK, there are two types of cross-talk. Signal flow: MAPK∗ pro-
teins slow signal flow through the TGF-β pathway by deactivating the R-
Smads and degrading Smad4. Gene expression: the TF∗ and AKT∗ proteins
upregulate gene expression in the TGF-β pathway. Note that the appearance
of the AKT and PI3K proteins in the MAPK pathway indicates an implicit
cross-talk with the AKT and PI3K pathways respectively. The inclusion of
cross-talk with the MAPK pathway can both provide alternative gene ex-
pression reactions and block signal flow through the TGF-β pathway, overall
causing the probability of the expression of Proteins within 5 time units, ψ2,
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to increase to 0.73. The probability of the eventual expression of Proteins,
ψ1, is 1 because the reactions in the MAPK pathway are not inhibited in the
model.
TGF-β and WNT Cross-talk. In the TGF-β and MAPK network, TGFB
|[. . .]| WNT , there are three types of cross-talk. Signal flow: the Smad7∗
protein degrades β-Catenin and the Axin protein degrades Smad7. Gene
expression: the β-Catenin protein upregulates gene expression in the TGF-
β pathway. Intracellular communication: the WNT pathway can cause the
production of a ligand for the TGF-β pathway, and vice-versa. The inclusion
of cross-talk with the WNT pathway can both provide an alternative gene
expression reaction and inhibit Smad7 which can inactivate the receptor for
the TGF-β pathway. Overall this causes the probability of the expression of
Proteins within 5 time units, ψ2, to increase to 0.76. The probability of the
eventual expression of Proteins, ψ1, is still < 1 due to the degradation of the
β-Catenin protein.
TGF-β, WNT and MAPK Cross-talk. The TGF-β, WNT and MAPK net-
work, (TGFB |[. . .]|MAPK) |[. . .]|WNT , is the union of the two cross-talk
scenarios above. The effect of both WNT and MAPK cross-talk to the TGF-
β pathway is additive. The probability of ψ2 rises to 0.88, compared with the
single cross-talks of WNT and MAPK with probability 0.76 and 0.73 respec-
tively. The inclusion of the MAPK cross-talk provides sets of reactions that
cause gene expression which cannot be inhibited and hence the probability
of ψ1 is 1.
We remark that we have categorised the complicated cross-talk in which
Axin degrades Smad7 unambiguously as signal flow. Whereas, in [21] there
is a suggestion that the cross-talk is receptor function because Axin degrades
the receptor (via Smad7, an intermediate). However, our approach does not
classify this cross-talk as receptor function cross-talk.
11. Discussion
Reversible reactions. We have simplified the biochemistry in this paper by
only considering irreversible reactions, e.g. the activation reaction X → X∗.
If our models were to include deactivation reactions, e.g. X∗ → X, then the
temporal logic properties would need to be strengthened. For example, the
property characterising signal flow cross-talk expresses that at some point
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in time R1 is inactive and Protein1 is expressed. If the activation of R1 is
a reversible reaction then this property is too weak. The property could be
satisfied if R1 becomes active, Protein1 is expressed and then R1 becomes
inactive. Thus, the correct property with reversible reactions is:
E [(R∗1 = 0) U (R
∗
1 = 0 ∧ Protein1 = 1)].
Cross-talk formalisation. Our cross-talk formalisation depends on the set of
modules being considered. One reason for this is that the modules act as
a proxy for the cellular location. For example, in the definition for Gene
Expression cross-talk, we disallow reactions from the Receptor module be-
cause gene expression occurs in the nucleus which is ‘far’ from the receptor.
Future work will be to introduce a formalisation that is not so strongly tied
to current set of modules. We expect to need, at the very least, a mapping
from the set of modules to the location of the modules.
Cross-talk generation and pathway generation. Our method to generate all
cross-talk models from a set of pathways (see Appendix A) could also be
applied to generate all pathway models from a set of modules. However, to
generate a pathway from a set of modules we would need to be careful that
all modules are connected and sometimes connected together in a specific
manner. Therefore, we would require a constraint to our method: a set of
reactions in each module that must synchronise with at least one reaction in
another module.
Quantitative detail. We have demonstrated our approach on models with a
low level of quantitative detail. As such, the probability values resulting
from CSL model checking can only be used to compare the models with each
other. However, with more quantitative detail, further interpretation of our
analysis results would be possible. For example, the properties concerning
the probability of time-dependent gene expression between cross-talk models
would become a meaningful assessment of the strength of the cross-talk.
Model-checking runtimes. The state spaces for all the models presented here
are small, e.g. of the order of 102. Runtimes for checking properties are
therefore trivial.
Feature interaction. There is an interesting analogy with feature interactions
in telecommunications and software systems. Features, or services, in these
systems are functionality additional to the core, added incrementally, by
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various developers, at various times (e.g. due to market deregulation). One
consequence of these uncoordinated additions is interactions between the
new features themselves, or with the core system, causing some features or
the core to behave in new, sometimes undesirable ways. One inspiration for
the approach to pathway cross-talk presented here is work on using temporal
logics to detect and characterise feature interactions [26]. An open question is
whether techniques developed to model and detect features and interactions
may be applicable to pathway cross-talk. For example, a common problem
is lack of universal definition of pathway/feature; it would be interesting to
investigate if concepts such as the feature construct of [27] would be useful
in the pathway paradigm. Finally, we note that in telecommunications, 3-
way feature interactions (a interaction between three features, that does not
occur between only two features) are very rare: most detection algorithms
depend on a pairwise analysis. This parallels cross-talk in which we have not
found a single example of cross-talk that is between three pathways.
Cross-talk categorisation. An interesting question that also plagues the fea-
ture interaction community is what is a feature and a feature interaction?
This is analogous to what is a pathway and a cross-talk, which begs the ques-
tion, is our cross-talk categorisation complete? We recall discussions with a
domain expert [25] that suggest a pathway is a dominant behaviour whereas
cross-talk is a side effect, which leads us to believe this is future work for the
biological, rather than the formal computer science, community.
The Molecular Nose research project. This work has been developed as part
of the Molecular Nose research project (see Acknowledgements). The project
aims to develop new in vivo sensor technologies for analysing and interpreting
cellular signal transduction networks. The term “molecular nose” refers to
sensor technology “sniffing out” pathways within a cell. Long term, we aim
to generate hypotheses about the structure of pathways and networks that
may explain cross-talks or pathway structures, comparing those in normal
cells with the same in diseased cells.
12. Conclusions and future work
We have defined a rigorous approach to modular modelling of pathways
and their cross-talk, based on generic modules and composition with syn-
chronisation, variable sharing, and reaction renaming.
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Our modelling style is reagent-centric, implemented in a state-based lan-
guage, which means that every reagent is mapped to a variable that denotes
a concentration level in an underlying CTMC with levels. While in stan-
dard reagent-centric modelling modules represent processes, here we define
generic modules that represent commonly occurring behavioural patterns
in signalling pathways. We then compose instances of modules, using the
standard (synchronising) parallel composition operator, to define a pathway.
Since composition is associative, this extends to pathways composed of any
number of modules.
A key aspect of a pathway is the distinction between external reactions
and variables, that are visible in the interface, and internal reactions and
variables, that are not visible. We then compose instances of pathways,
again using the standard (synchronising) parallel composition operator, to
define a network of pathways. If the intersection of the interfaces of the two
pathways is empty, then the two pathways are considered independent. The
pathways can be “wired” together, i.e. to make the pathways cross-talk, in
a combinatorial manner by renaming and synchronising external reactions
and by sharing variables. Again, by associativity, this extends to networks
of any number of pathways. Also, it is easy to remove any results that are
clearly biochemically infeasible. This approach allows us to both explore
all possible cross-talks between pathways and to explain a given network in
terms of pathways.
We have defined 5 different types of cross-talk, these have been alluded
to in the literature but not previously defined formally. Generation of the
different types of cross-talk is given by two simple algorithms; detection
and characterisation of the different types of cross-talk is by qualitative and
quantitative logic property model checking. We are able to show, from a basic
set of modules, that every type of cross-talk can be generated and detected.
Throughout, we use the state based PRISM modelling language, a language
of guarded commands with process algebraic composition, with two minor
extensions.
We apply the approach to a prominent example of cross-talk between the
three pathways: TGF-β, WNT and MAPK. We both detect and categorise
9 cross-talks.
Several future directions have been identified. As suggested earlier, longer
term, we will apply our approach to models with a higher level of quantitative
detail: to make better predictions and gain further insights into the biological
effects of cross-talk. We will also consider the relationship between cross-talks
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and standard pathway motifs. For example, is there a reasonable alteration
of a pathway model (e.g. addition of a feedback loop) that gives the same
behaviour as a potential cross-talk? We will also assess how the effectiveness
of pathway intervention techniques such as drugs and gene knockouts change
with the addition of cross-talk. Finally, a larger question is how the temporal
ordering of signals affects the detectability and behaviour of cross-talk; for
example, do pathways hold a “biochemical history” of signalling events?
The cross-talk generation program (incl. source code), PRISM models
and logic properties used in this paper can be found at:
www.dcs.gla.ac.uk/~radonald/jtb2011/.
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Appendix A. Cross-talk generation
We describe below a method to generate every cross-talk between two
pathways P1 and P2. First, we consider substrate availability cross-talk and
then, all other types of cross-talk.
To generate every substrate availability cross-talk we share between path-
ways every pair of (external) variables.
for variable v ∈ extv(P1) do
for variable w ∈ extv(P2) do
P1 {renamings1} |[E ∪ U, V ]| Pathway2 {renamings2} where U =
aux(P1) ∪ aux(P2), E = ∅, renamings1 = ∅, renamings2 = ∅ and
V = {(v, w)}
end for
end for
To generate every cross-talk of all other types we create all possible can-
didate cross-talks by synchronising up to k (external) reactions.
for i ≥ 1, j ≥ 1 such that i+ j ≤ k do
for X = choose i reactions from extr(P1) do
for Y = choose j reactions from extr(P2) do
if X ∪ Y contains only modifiers then skip else
P1 {renamings1} |[E ∪ U, V ]| P2 {renamings2} where
renamings1 such that ∀x ∈ X.x← rnew, renamings2
such that ∀y ∈ Y.y ← rnew, E = {rnew} and
U = (aux(P1 {renamings1}) ∪ aux(P2 {renamings2}))
\ mapped(rnew),
end for
end for
end for
We then filter the candidate cross-talks according to the categorisation –
those cross-talks that are not categorised are removed.
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